CVS Health Corp
CVS- Exchange
- NYSE
- Industry
- Retail-Drug Stores and Proprietary Stores
- SEC CIK
- 0000064803
In the last 90 days, CVS Health Corp insiders filed 1 open-market purchase and 0 sales; 2,085 institutions reported holding it in 13F filings for Q2 2026, worth $117.5B in total; 3 superinvestors hold it, including Viking Global Investors and Fairfax Financial.
- Currency
- USD
- Source
- SEC XBRL data (10-K, 10-Q, 20-F, 40-F)
- Updated
- Nov 5, 2026, 12:03 AM ET
Revenue flow, FY2025
Where the revenue went in FY2025, from the income statement below. Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue; hover over a band or a bar for the exact amount.
Income statement
Each column is one fiscal year, newest first.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Period end | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | Feb 10, 2026 | Feb 12, 2025 | Jan 5, 2024 | Jan 9, 2023 | Jan 11, 2022 |
| Revenue | $402.1B | $372.8B | $357.8B | $322.5B | $292.1B |
| Cost of revenue | $221.2B | $206.3B | $217.1B | $196.9B | $175.8B |
| Operating income | $4.66B | $8.52B | $13.7B | $7.75B | $13.2B |
| Interest expense | – | – | $2.66B | $2.29B | $2.50B |
| Income tax | $408.0M | $1.56B | $2.81B | $1.46B | $2.52B |
| Net income | $1.77B | $4.61B | $8.34B | $4.15B | $7.91B |
| EPS, basic | $1.40 | $3.67 | $6.49 | $3.16 | $6.00 |
| EPS, diluted | $1.39 | $3.66 | $6.47 | $3.14 | $5.95 |
| Weighted shares, basic | 1.27B | 1.26B | 1.28B | 1.31B | 1.32B |
| Weighted shares, diluted | 1.27B | 1.26B | 1.29B | 1.32B | 1.33B |
| Margins and growth | |||||
| Operating margin | 1.2% | 2.3% | 3.8% | 2.4% | 4.5% |
| Net margin | 0.4% | 1.2% | 2.3% | 1.3% | 2.7% |
| Revenue growth, year over year | +7.8% | +4.2% | +10.9% | +10.4% | +8.7% |
| Net income growth, year over year | −61.7% | −44.7% | +101.1% | −47.5% | +10.2% |
Balance sheet
Each column is one fiscal year, newest first.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Period end | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | Feb 10, 2026 | Feb 12, 2025 | Jan 5, 2024 | Jan 9, 2023 | Jan 11, 2022 |
| Cash and equivalents | $8.45B | $8.59B | $8.20B | $12.9B | $9.41B |
| Short-term investments | $2.15B | $2.41B | $3.26B | $2.78B | $3.12B |
| Accounts receivable | $39.8B | $36.5B | $35.2B | $27.3B | $24.4B |
| Inventory | $19.2B | $18.1B | $18.0B | $19.1B | $17.8B |
| Total current assets | $74.7B | $68.6B | $67.9B | $65.7B | $60.0B |
| Property, plant and equipment | – | – | – | $12.9B | $12.9B |
| Goodwill | $85.5B | $91.3B | $91.3B | $78.2B | $79.1B |
| Intangible assets | $25.5B | $27.3B | $29.2B | $24.8B | $29.0B |
| Total assets | $253.5B | $253.2B | $249.7B | $228.3B | $233.0B |
| Short-term debt | $0 | $2.12B | $200.0M | – | – |
| Total current liabilities | $88.7B | $84.6B | $79.2B | $69.7B | $67.8B |
| Total liabilities | $178.2B | $177.5B | $173.1B | $157.0B | $157.6B |
| Shareholders' equity | $75.4B | $75.7B | $76.6B | $71.3B | $75.4B |
Cash flow statement
Each column is one fiscal year, newest first. Free cash flow is operating cash flow minus capital expenditures.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Period end | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | Feb 10, 2026 | Feb 12, 2025 | Jan 5, 2024 | Jan 9, 2023 | Jan 11, 2022 |
| Operating cash flow | $10.6B | $9.11B | $13.4B | $16.2B | $18.3B |
| Capital expenditures | $2.83B | $2.78B | $3.03B | $2.73B | $2.52B |
| Free cash flow | $7.81B | $6.33B | $10.4B | $13.4B | $15.7B |
| Depreciation and amortization | $4.61B | $4.60B | $4.37B | $4.25B | $4.51B |
| Stock-based compensation | $535.0M | $540.0M | $588.0M | $447.0M | $484.0M |
| Dividends paid | $3.40B | $3.37B | $3.13B | $2.91B | $2.63B |
| Share buybacks | $0 | $3.02B | $2.01B | $3.50B | – |
| Investing cash flow | -$5.87B | -$7.61B | -$20.9B | -$5.05B | -$5.26B |
| Financing cash flow | -$4.94B | -$1.14B | $2.68B | -$10.5B | -$11.4B |
| Net change in cash | -$172.0M | $359.0M | -$4.78B | $614.0M | $1.65B |
| Ratio | |||||
| Stock-based compensation, % of revenue | 0.1% | 0.1% | 0.2% | 0.1% | 0.2% |
Shares outstanding
Common shares outstanding as stated on the cover of each 10-K and 10-Q. The date is the cover date, not the period end; a rising count means dilution.
| Cover date | Shares outstanding | Change in a year | Filing |
|---|---|---|---|
| Oct 28, 2026 | 1.28B | +0.8% | SEC |
| Jul 29, 2026 | 1.28B | +0.8% | SEC |
| Apr 29, 2026 | 1.28B | +0.9% | SEC |
| Feb 4, 2026 | 1.27B | +0.9% | SEC |
| Oct 22, 2025 | 1.27B | +0.9% | SEC |
| Jul 23, 2025 | 1.27B | +0.8% | SEC |
| Apr 23, 2025 | 1.27B | +0.8% | SEC |
| Feb 5, 2025 | 1.26B | +0.2% | SEC |
Notes and known gaps
How these numbers are put together, and what they can't tell you.
- Numbers come from the XBRL data in each period's original 10-K, 10-Q, 20-F or 40-F, or its amendment. They are shown as filed: later filings don't restate earlier periods here.
- Reported is the filing date of the first 8-K with Item 2.02 (results of operations) after the period ended, no later than the 10-Q or 10-K and within 120 days. Companies that release results only in the 10-Q, and foreign companies, which use Form 6-K, have none.
Known gaps
- Foreign companies that file Form 20-F or 40-F have annual statements only: their quarterly results are furnished on Form 6-K, which has no XBRL data.
- EPS and share counts are as reported at the time, not adjusted for later stock splits.
- For ADRs, EPS is per ordinary share, not per ADS (one TSMC ADS is five ordinary shares).
- For banks, revenue may be interest income only, depending on how the bank tags its filings; cost of revenue and gross profit are usually blank.
- Companies with several share classes, such as Berkshire Hathaway, may have no EPS and no cover share count.
- Depreciation and amortization is missing for some companies that report it under their own XBRL tags.